Octapharma has released the results from its prospective, randomized, double-blind, parallel group, crossover, placebo-controlled phase 3 study comparing the effectiveness of PANZYGA® (immune globulin ...

Circulate Health, the company dedicated to harnessing the potential of therapeutic plasma exchange (TPE) to advance human healthspan and lifespan, today announces the publication of a single blind, ...

SCTIMST transfers 5 medical device technologies to industry, including DBS system, electrodes, plasma fractionation, and wound dressings.

Radicle Science, a health tech company bringing trusted clinical evidence to everyday wellness and natural products, welcomes Liya Sharif Lancia as its chief marketing officer. This latest addition to ...

Hyderabad: In a rare medical development, a highly sensitised kidney failure patient in Nandyal, Andhra Pradesh, has ...

A first-of-its-kind clinical trial clinical trial shows that therapeutic plasma exchange (TPE) combined with intravenous ...

Due to the autoimmune etiology of this disorder, IV immunoglobulin (IVIg) or plasma exchange (PE) are the first-line treatments in addition to management of ventilatory failure. IVIg is more ...

Currently, its availability is not widespread, there is no intravenous preparation and oral preparations require several days of administration to reach optimal effects. A further problem with ...

High-dose intravenous immunoglobulin is a widely used therapeutic preparation of highly purified immunoglobulin G (IgG) antibodies. It is administered at high doses (1–2 grams per kilogram) for ...

intravenous immunoglobulin (IVIG): Antibodies obtained from donor plasma; the medication is used intravenously to block inflammation. IVIG is mostly used in Catastrophic Antiphospholipid Syndrome.